# Dronedarone

## Multaq 400mg

#### 本院臨採清單

| 藥品代碼       | OMUL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Paroxysmal or persistent atrial fibrillation: To reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量       | 400 mg twice daily with meals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌           | Hypersensitivity to dronedarone or any component of the formulation; permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored); symptomatic heart failure (heart failure with recent [within the last 4 weeks] decompensation requiring hospitalization or NYHA Class III or IV symptoms); liver or lung toxicity related to previous amiodarone use; second-degree or third-degree atrioventricular block or sick sinus syndrome (except when used in conjunction with a functioning artificial pacemaker); bradycardia <50 bpm; concomitant use of strong CYP3A4 inhibitors (eg， ketoconazole， itraconazole， voriconazole， cyclosporine， telithromycin， clarithromycin， nefazodone， ritonavir); concomitant use of drugs or herbal products known to prolong the QT interval increasing the risk for torsade de pointes (eg， phenothiazine antipsychotics， tricyclic antidepressants， certain oral macrolide antibiotics， class I and III antiarrhythmics); QTc (Bazett) interval ?500 msec or PR interval >280 msec; severe hepatic impairment; pregnancy; breastfeeding |
| 副作用         | >10%: Cardiovascular: Prolonged Q-T interval on ECG (Bazett; 28% [placebo: 19%]; defined as >450 msec in males or >470 msec in female); Renal: Increased serum creatinine (51%; increased >10%; occurred 5 days after initiation) 1% to 10%: Cardiovascular: Bradycardia (3%); Dermatologic: Allergic dermatitis (<=5%)， dermatitis (<=5%)， eczema (<=5%)， pruritus (<=5%)， skin rash (<=5%; described as generalized， macular， maculopapular， erythematous); Gastrointestinal: Diarrhea (9%)， nausea (5%)， abdominal pain (4%)， dyspepsia (2%)， vomiting (2%); Neuromuscular & skeletal: Weakness (7%) <1%， postmarketing， and/or case reports: Acute hepatic failure (requiring transplant)， anaphylaxis， angioedema， atrial flutter (with 1:1 atrioventricular conduction)， cardiac failure (new or worsened)， dysgeusia， hepatic injury， hyperbilirubinemia， hypersensitivity angiitis， increased blood urea nitrogen， increased liver enzymes， interstitial pulmonary disease， pneumonitis， pulmonary fibrosis， skin photosensitivity， vasculitis                                                |
| 孕期用藥建議   | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

